Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David M. Sudekum"'
Publikováno v:
American Journal of Health-System Pharmacy
American Journal of Health-System Pharmacy: AJHP
American Journal of Health-System Pharmacy: AJHP
Purpose The global coronavirus disease 2019 (COVID-19) pandemic has created unprecedented strains on healthcare systems around the world. Challenges surrounding an overwhelming influx of patients with COVID-19 and changes in care dynamics prompt the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f99186e431df81f00537faa9899f72
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 30:105959
To assess the safety and efficacy of continuous infusion (CIV)-labetalol compared to -nicardipine in controlling blood pressure (BP) in the acute stroke setting.Patients were eligible if they had a diagnosis of an acute stroke and were administered e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855cbe204a5802da3a4cada0cf8ec8ef
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105959
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105959
Autor:
David M. Sudekum, Shikha Polega, Patrick G. Richards, Kimberlyn M. Dang, Nina West, Beena Cheriyan, Curtis D. Collins, Anurag N. Malani, Michelle Brinker-Bodley, Lisa Kerr, Carol A. Kauffman, Kay Lyn Stalker
Publikováno v:
Journal of Antimicrobial Chemotherapy. :dkw550
A high-dose 12 mg/kg/day (6 mg/kg twice daily) voriconazole regimen was recommended by the CDC to treat patients injected with contaminated methylprednisolone acetate that caused a multi-state fungal outbreak in 2012-13. Therapeutic drug monitoring r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1233fd6355377154931f733f037fee64
https://doi.org/10.1093/jac/dkw550
https://doi.org/10.1093/jac/dkw550
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 68(9)
Purpose The stability of extemporaneously prepared glycopyrrolate 0.5-mg/mL suspensions was evaluated. Methods An oral suspension of glycopyrrolate 0.5 mg/mL was prepared by thoroughly grinding 30 1-mg tablets of glycopyrrolate in a glass mortar. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4bdd67935fd3eb53321d4979831d90b
https://pubmed.ncbi.nlm.nih.gov/21515869
https://pubmed.ncbi.nlm.nih.gov/21515869